Clinical Trial Update: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fatty acid supplementation for Dermatomyositis and Juvenile Dermatomyositis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Juvenile Dermatomyositis

Drugs mentioned

• Fatty acid supplement

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Dermatomyositis (DM), Juvenile Dermatomyositis (JDM) | Phase 2 | Status: RECRUITING